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Abstract
Acinetobacter baumannii is a highly potent nosocomial pathogen that is associated with
increased in-hospital mortality. Here, we investigated the changes in molecular characteris-
tics of carbapenem-resistant A. baumannii (CRAB) isolated from the blood samples of
patients admitted to a tertiary hospital in South Korea from January 2009 to July 2015.
Whole genome sequencing using the Illumina MiSeq platform and multi-locus sequence typ-
ing (MLST) were performed for 98 CRAB clinical isolates. In silico analyses for the prediction
of antimicrobial resistance and virulence factor genes were performed. Plasmid sequences,
including complete forms, were reconstructed from the sequence reads. Epidemiologic data
were collected from the hospital database. MLST using the Oxford scheme revealed 10
sequence types of CRAB, of which ST191 was the dominant type (n = 59). Although blaOXA-
23 was shared by most analysed strains, the compositions of antimicrobial resistance deter-
minants differed among sequence types. ST447 and ST451/ST1809 with a few resistance
genes were isolated during the later years of the study period. The number of virulence
genes increased, while that of ST191 did not change significantly over the investigation
period. Intriguingly MLST types, compositions of antimicrobial resistance genes, and viru-
lence genes had no association with clinical outcomes of CRAB bacteraemia. In conclusion,
active changes in or accumulations of antimicrobial resistance determinants and virulence
genes in CRAB were not observed during the research period. Molecular characteristics of
CRAB had no association with clinical outcomes of CRAB bacteraemia.







Citation: Kim MH, Jeong H, Sim YM, Lee S, Yong
D, Ryu C-M, et al. (2020) Using comparative
genomics to understand molecular features of
carbapenem-resistant Acinetobacter baumannii
from South Korea causing invasive infections and
their clinical implications. PLoS ONE 15(2):
e0229416. https://doi.org/10.1371/journal.
pone.0229416
Editor: Zhi Ruan, Zhejiang University, CHINA
Received: November 6, 2019
Accepted: February 5, 2020
Published: February 21, 2020
Copyright: © 2020 Kim et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: This work was supported by Korea HIV/
AIDS Cohort Study (Grant No. 2019-ER5101-00),
Ministry of Health & Welfare, South Korea (Grant
No. HI14C1324), Ministry of Science, ICT & Future
Planning, South Korea (Grant No. H-
GUARD_2013M3A6B2078952), a Severance
Introduction
Acinetobacter baumannii is an aerobic gram-negative coccobacillus known for relatively few
virulence factors as compared to other gram-negative pathogens [1]. Its ability to acquire vari-
ous antimicrobial resistance genes makes it a highly successful nosocomial pathogen, which is
associated with increased in-hospital mortality [2]. In particular, the prevalence of carbape-
nem-resistant A. baumannii (CRAB) isolates is on the rise in Asian countries, including South
Korea [3,4]. The specific clone, international clone 2 (IC II), is a major clonal group among
Korean CRAB isolates [5]. This organism is associated with nosocomial outbreaks and multi-
drug resistance in association with blaOXA-23-like genes [6]. In a recent study, 75% of A. bau-
mannii clinical isolates were shown to belong to IC II in Korea [7], and IC II was recognised as
the second most common cause of bacteraemia from 2012 to 2013 [8].
Considering the threat of the increasing incidence of CRAB infection, prediction of future
effects of these isolates is a priority. Whole genome sequencing (WGS) analysis provides
unprecedented information about this illusive organism, especially for the characterisation of
nosocomial outbreaks [9,10]. WGS provides in-depth epidemiologic knowledge by providing
higher resolution in genotyping and suggesting the emergence of new epidemic clones. WGS
also helps researchers to understand the various mechanisms underlying the acquisition of
antimicrobial resistance genes. Antimicrobial resistance genes were found in alien islands of
accessory genomes and were often accompanied by integrases, transposases, or insertion
sequences suggestive of their possible acquisition by horizontal gene transfer from other Acine-
tobacter spp. or bacteria that colonise the same environment [11,12]. Furthermore, although
little is known about the virulence factors of this bacterium as compared to the current knowl-
edge about antimicrobial resistance mechanisms [13], the rapid increase in the number of
sequenced and annotated genomes has enabled comparative genomic analyses to elucidate
clues concerning potential virulence factors.
Previous studies compared the distribution of genes related to virulence and antimicrobial
resistance to understand phenotypic differences between isolates [14–16]. However, a compre-
hensive analysis of the number of virulence or AMR genes in association clinical outcomes has
not been performed. This analysis may provide some insight into how this organism is evolv-
ing in epidemiologic perspective. Therefore, we attempted a whole genome-association study
by sequencing all available isolates from patients with CRAB bacteraemia to characterise the
genomic changes over the study period from the epidemiological perspective and investigated
the clinical significance of genomic characteristics of CRAB. These investigations of the genetic
characteristics, including antimicrobial resistance determinants and virulence factors of CRAB
blood isolates, can over time provide insight into how the organism evolves and may suggest
clinico-epidemiological implications of genomic characteristics of this organism.
Materials and methods
Ethics statement
This study was approved by the Institutional Review Board (IRB) of Yonsei University Health
System Clinical Trial Center (4-2017-0730). Since the study had minimal health risk and the
study subjects were anonymised, the Institutional Review Board waived the requirement for
written informed consent from the patients.
Collection of bacterial isolates and patient information
Blood isolates from patients with CRAB bacteraemia were collected between January 2009 and
July 2015 at intensive care units (ICUs) of Severance Hospital in Seoul, Republic of Korea.
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CRAB bacteraemia was defined as one or more positive blood cultures for carbapenem-resis-
tant A. baumannii and the presence of clinical features compatible with systemic inflammatory
response syndrome. Preliminary species identification and antimicrobial susceptibility tests
were conducted with VITEK II system (bioMérieux, Marcy l’Etoile, France). Disc-diffusion
testing using antimicrobial discs (Becton Dickinson, Sparks, MD, USA) on cationic-adjusted
Mueller–Hinton (MH) agar (Difco Laboratories, Detroit, MI, USA) was subsequently per-
formed as per CLSI guidelines [17]. Minimum inhibitory concentrations (MICs) to three
drugs including tigecycline, minocycline and colistin were assessed using VITEK II system.
The MICs of imipenem and meropenem were determined with the agar dilution method
using MH agar following CLSI guidelines [17]. Additionally, modified Hodge tests and dou-
ble-disk synergy tests were performed to screen carbapenemase and metallo-β-lactamase activ-
ity, respectively.
We collected clinical data, including patients’ age and sex, length of ICU stay, length of hos-
pital stay, pre-existing chronic comorbidities (diabetes, chronic heart failure, chronic liver dis-
ease, chronic renal disease, and chronic pulmonary disease), sequential organ failure
assessment score, episodes of hospital admission, previous invasive procedures (central line
insertion, intubation, continuous renal replacement therapy, and surgery under general anaes-
thesia), as well as lengths and types of antibiotic treatments. The origin of bacteraemia was
determined upon identification of precedent CRAB isolation or evidence of infection before
the event of bacteraemia.
Whole genome sequencing (WGS), annotation, prediction of antimicrobial
resistance determinants, and identification of virulence genes
The isolates were cultured in Luria Bertani (LB) broth, and genomic DNA was extracted with
a PureHelix™ Genomic DNA Prep Kit (cat. no. GCTN100, Nanohelix, Daejeon, Republic of
Korea). Paired end sequencing of 98 A. baumannii clinical isolates was carried out using the
Illumina MiSeq platform at ChunLab (Seoul, Republic of Korea). Specifically, TruSeq Nano
DNA Library Preparation Kit (550 bp library size) and MiSeq Reagent Kit v3 (600 cycles) were
used. Using CLC Genomics Workbench v11.0.1 (https://www.qiagenbioinformatics.com/),
reads were trimmed (quality limit 0.01, ambiguous limit 1, min length 120 bp, discarding
orphan reads) and were de novo assembled. Word and bubble sizes were 64 and 100, respec-
tively. The assembled genome sequences were annotated using NCBI’s Prokaryotic Genome
Annotation Pipeline (PGAP) v4.5 [18]. GenBank files produced from PGAP were converted to
GFF format, and then subjected to Roary [19] to obtain core genome sequences and their
codon-aware alignments, followed by a heuristic method-based automated trimming using tri-
mAl [20]. A phylogenetic tree was constructed using FastTree2 [21] and visualised using iTOL
server [22].
To identify antimicrobial resistance genes, the contig sequences were queried against the
ResFinder database (https://cge.cbs.dtu.dk/services/data.php; downloaded on June 4, 2018)
using Find Resistance v1.01 from the Microbial Genomics Module of CLC Genomics
Workbench.
A comprehensive list of virulence factors from A. baumannii was compiled as per the previ-
ous studies [23–26]. The list of 182 virulence genes is shown in S1 Table. Distribution of viru-
lence genes across all genomes was obtained using the large-scale blast score ratio (LS-BSR)
[27]. A cut-off value of blast score ratio 0.7 was arbitrarily selected to evaluate the existence of
each virulence gene.
For comprehensive genomic epidemiological analysis, we used BacWGSTdb (http://bacdb.
org/BacWGSTdb) [28] which allows us to find closest isolates that are currently deposited in
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NCBI GenBank database. Scheme core genome multi-locus sequence typing (cgMLST) was
used with a 50 threshold for single nucleotide polymorphism (SNP) and a 50 threshold for
MSLT.
Multi-locus sequence typing (MLST) and detection of single nucleotide
polymorphism (SNP)
Allelic profiles or STs of each isolate were determined by submitting contig sequences to the
PubMLST site (https://pubmlst.org/abaumannii/) according to the Institute Pasteur scheme
(MLST-IP) and Oxford Database (MLST-OD).
SNPs were identified by mapping raw sequencing reads to the complete chromosome
sequence of A. baumannii strain KBN10P02143 (GenBank CP013924.1), the multidrug strain
that completely sequenced for the first time in South Korea, using Snippy (https://github.com/
tseemann/snippy).
Analysis of plasmid sequences
Plasmid sequences were constructed either by plasmidSPAdes [29] assembler that uses the
read coverage of contigs, or by a custom three-step method consisting of (i) running Plasmid
Profiler [30] that first identifies putative plasmid hits from the plasmid database, (ii) mapping
of the entire reads to chosen plasmid sequences using SMALT (https://www.sanger.ac.uk/
science/tools/smalt-0) and extracting paired reads where at least one end mapped using SAM-
TOOLS (http://www.htslib.org/), and finally, (iii) assembly of the extracted reads using UniCy-
cler [31]. Assembly statistics and whole-genome assembly results are shown in S2 Table.
Complete (also circularised) plasmid sequences were identified from UniCycler assemblies by
visualization of assembly graphs using Bandage [32]). Putative protein coding genes were pre-
dicted using GeneMarkS [33], and rep genes were identified by hmmsearch (http://hmmer.
org/) against Pfam database v31.0 (https://pfam.xfam.org/).
Identification of insertion sequences and transposons
The blaOXA-23 is a major determinant of nosocomial outbreaks of IC II CRAB. The expression
of this gene is presumably regulated by several insertion sequences, including ISAba1, which is
thought to play the most crucial role in gene expression [34]. ISMapper [35] was used to iden-
tify ISAba1 insertion sites on the reference genome of the strain KBN10P02143. Insertion sites
of ISAba1 relative to the chromosome of KBN10P02143 are shown in S3 Table. The presence
of blaOXA-23-carrying transposons, including Tn2006, Tn2007, Tn2008, and Tn2009, was
screened using Primersearch from the EMBOSS package (http://emboss.sourceforge.net/),
with primer sets suggested by Chen et al. [36].
Statistical analysis
Baseline characteristics were compared using Mann–Whitney U test or independent samples
t-test for continuous variables, and by χ2 test or Fisher’s exact test for categorical variables.
Continuous variables were expressed as means or medians (interquartile ranges), while cate-
gorical variables were expressed as numbers with percentages for the description of baseline
characteristics. Statistical analyses were performed using SPSS version 21.0 (IBM Corp.,
Armonk, NY, USA).
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Data availability
Genome sequences were submitted to GenBank under BioProject no. PRJNA448358 (https://
www.ncbi.nlm.nih.gov/bioproject/PRJNA448358). The complete list of strain names and
accession numbers are shown in S2 Table. Complete sequences of five representative plasmids
(pABAY04001_1A, pABAY09008_1B, pABAY10001_1C, pABAY14012_4D, and
pABAY15001_6E) are available from GenBank under the accession numbers MK386680.1-
MK386684.1. All 115 complete plasmid sequences and their rep genes are available at https://
doi.org/10.6084/m9.figshare.11467023.v1 (figshare).
Results
Overview of A. baumannii isolates
A total of 109 CRAB blood isolates were used in this study. Of these, three samples with possi-
ble contamination and eight samples with insufficient clinical data were excluded. The remain-
ing 98 samples were consequently included in the analysis. The isolates exhibited a high rate of
resistance for almost all the antibiotics tested: 92.7% were resistant to gentamycin (89/96),
88.8% to amikacin (87/98), 100% to imipenem (98/98), 98.8% to ciprofloxacin (84/85), 97.8%
to levofloxacin (96/98), 98.9% to piperacillin-tazobactam (92/93), 98.9% to ceftazidime (96/
97), 96.9% to cefepime (95/98), 4.3% to colistin (4/92), and 11.1% to tetracycline (1/9) (S4
Table).
MLST analysis depending on isolation years
An MLST using Pasteur scheme identified 93 strains (94.9%) that were classified into ST2,
indicating that most of the strains belonged to IC II. MLST using Oxford scheme was applied
to assign 10 STs (ST858, ST369, ST208/ST1806, ST784, ST451/ST1809, ST357, ST368, ST447,
ST552, and ST191). ST191 was the most abundant type (59 strains). Strains ABAY12003 and
ABAY13017, single variants of ST191 at gyrB and rpoD, respectively, were not assigned any
STs. As a result, we found that 91 strains (92.9%), all belonging to IC II, had two incidences of
gdhB alleles, 3 and 189, which made distinctions between ST208, ST1806, ST451, and ST1809
ambiguous. Although all ST191 strains had two gdhB alleles, only the ABAY15007 strain har-
bouring gpi-94 gpi-107 was equivocally assigned to ST191 and ST784.
ST191 was evenly isolated throughout the research period. ST368 (n = 3), ST552 (n = 1),
ST369 (n = 3), ST357 (n = 7), and ST208/ST1806 (n = 5) were mostly isolated from 2009 to
2012, while ST447 (n = 4), ST451/ST1809 (n = 11), ST858 (n = 1), ST784 (n = 1), and ST191/
ST784 (n = 1) were mostly reported from 2013 to 2015 (Fig 1 and Table 1).
Core genome-based phylogeny and SNP-based inference of recombination
A core genome alignment-based phylogenetic tree was constructed to delineate the in-depth
relationships between analysed strains (Fig 2). The analysis resulted in the classification of 98
analysed strains into four major clades. SNP identification relied on read mapping on the ref-
erence genome sequence of strain KBN10P02143. Pairwise SNP distances among all strains
ranged from 39 to 83,304 bp (5,368 bp median) (S5 Table). Relationships between SNP-based
phylogeny and STs were searched. Clade 1 was mostly composed of ST191. The majority of
strains classified as clade 2 (ST368, ST357, and ST858) were isolated in the former part of our
study period, while those of clade 3 (ST208/ST1806 and ST369) were isolated in the latter part.
However, chronological correlation among clades was not identified overall.
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Differences in patient characteristics among STs
Patients were hospitalised in different types of ICUs, and the locations of each isolated ST are
shown in Table 1. Most strains were identified in MICU, and no notable relationship between
isolated locations and STs was reported. The mean age of the enrolled patients was
60.62 ± 14.63 years, and male patients predominated (70.4%, n = 69). Chronic obstructive pul-
monary disease was the most commonly found underlying morbidity (93.9%, n = 92), and che-
motherapy was the most common cause of immunosuppression (39.8%, n = 39). Ventilator
care was performed in 81.6% of patients (n = 80). The most common source of bacteraemia
was the respiratory tract (79.6%, n = 78). The median number of hospitalisation days was 30
[19–64.2], and patients used antibiotics for a median treatment length of 30.5 [16–59.3] days.
The all-cause 28-day mortality was 80.6% (n = 79). No significant differences were observed in
clinical characteristics among STs except for the following. Patients with strains typed as
ST447 Patients with strains typed as ST447 spent less time in the hospital (17 [17–41] days ver-
sus 30 [19–64.2] days, p< 0.05) and there were fewer males among patients with strains typed
as ST191 (40 [63.5%] versus 29 [82.9%], p< 0.05) (Table 2).
Analysis using BacWGSTdb based on MLST strategy revealed that 48 (48/98, 49.0%) strains
had no closely related strains. The other strains had close relationships with clinical isolates
identified in South Korea. The only strain that was linked to isolates outside of South Korea
was ABAY09002 (closely related to GeneBank JRQX01, isolated in Thailand in January, 2010).
The rates of strains that showed no relatedness with previously identified strains were as fol-
lows: ST191, 40.0% (23/59); ST368, 66.6% (2/3); ST552, 100%(1/1); ST357, 71/43%(5/7);
ST208/ST1806, 100%(5/5); ST369, 100%(3/3); ST451/ST1809, 9.1%(1/11); ST8958, 100%(1/1);
ST784, 100%(1/1); ST191/ST784, 100%(1/1); ST447,25.0%(1/4); Not applicable (NA), 100%(2/
2).
Differences in antimicrobial resistance determinants according to STs and
year of isolation
Among 29 AMR genes investigated, an average of 16.64 genes were possessed by each strain.
The gene blaOXA-23 was identified in all strains except for ABAY11010 (ST369) and
Fig 1. Distribution of carbapenem resistance A. baumannii isolates according to sequence types and year of isolation. The isolates
were typed by multi-locus sequence typing (MLST) using Oxford scheme and colored individually according to sequence type. Bar
graph represents the individual and cumulative numbers of strains isolated each year.
https://doi.org/10.1371/journal.pone.0229416.g001
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ABAY12016 (ST208/ST1806). Among class D carbapenem-hydrolysing class D β-lactamase
genes, blaOXA-82 and blaOXA-66 were found in ABAY11010 and ABAY12016, respectively.
The composition of antimicrobial resistance determinants within each ST was relatively
constant, especially in ST191. As we compared the first half of the research period with the lat-
ter half, only strA (0%, n = 0 versus 18.2%, n = 4; p = 0.02) showed increased prevalence. Fur-
thermore, we observed a decrease in the prevalence of aac(3)-Ia (9.1%, n = 2 versus 91.9%,
n = 34; p< 0.01), armA (86.4%, n = 19 versus 100%, n = 37; p = 0.04), and blaTEM-1D (18.2%,
n = 4 versus 97.3%, n = 36; p< 0.01). The comparison of sources of bacteraemia showed that
aadA1b was more common in isolates from the respiratory tract than in isolates from any
other sources (51.9%, n = 14 versus 0%, n = 0; p< 0.01) (Table 3).
However, we observed clear distinctions in the composition of AMR genes among ST
types. ST447 and ST451/ST1809, which were the dominant STs in the latter part of our study,
had the least amount of AMR genes. In these types, aac(6')-Ib, aac(6')-Ib, aadA1, ant(3'')-Ia,
and sul1 were less frequently detected, while sul2 and tet(B) were the more frequently observed
Table 1. Sequence types of carbapenem resistant A. baumannii (CRAB) and epidemiologic information.
Group (N) Phylogenetic clade Pasteur ST (N) Oxford ST (N) Isolated location (N) Isolated year (N) Origin of bacteremia
IC II Clade 1 ST2 (93) ST191 (59) MICU A (15) 2009 (11) Respiratory tract (46)
MICU B (24) 2010 (5) Gastrointestinal tract (3)
MICU C (7) 2011 (10) Musculoskeletal (1)
MICU D (5) 2012 (11) Catheter (6)
NCU B (1) 2013 (12) Other (2)
SICU (2) 2014 (5)
CCU A (1) 2015 (5)
CCU B (2)
Clade 2 ST368 (3) MICU B (2) 2009 (2) Respiratory tract (3)
CCU A (1) 2012 (1)
Clade 2 ST357 (7) MICUA(5) 2010 (1) Respiratory tract (7)
MICUB(1) 2011 (3)
MICU D (1) 2012 (3)
Clade 3 ST208/ST1806 (5) MICU B (2) 2011 (1) Other (1)
MICU C (1) 2012 (3)
MICU D (1) 2013 (1)
Clade 3 ST369 (3) MICU A (1) 2011 (1) Respiratory tract (2)
MICU D (2) 2013 (2) Other (1)
Clade 2 ST858 (1) MICU C (1) 2013 (1) Respiratory tract (1)
Clade 4 ST451/ST1809 (11) MICU A (6) 2013 (1) Respiratory tract (9)
MICU B (4) 2014 (6) Urinary tract(1)
CCU A (1) 2015 (4) Gastrointestinal tract (1)
Clade 1 ST784 (1) MICU C (1) 2015 (1) Musculoskeletal (1)
Clade 1 ST191/ST784 (1) MICU B (1) 2015 (1) Respiratory tract (1)
Non-IC II NA ST193 (1) ST552 (1) CCU A (1) 2010 (1) Respiratory tract (1)
NA ST10 (4) ST447 (4) MICU A (2) 2013 (1) Respiratory tract (4)
MICU B (2) 2014 (3)
NA NA NA ABAY12003 MICU A (1) 2012 (1) Respiratory tract (1)
ABAY13017 MICU A (1) 2013 (1) Catheter (1)
Data are expressed as number (N). Abbreviation: ST, sequence type; IC II, international clone II; MLST, Multi-locus sequence typing; MICU, medical intensive care
unit; NCU, neurologic intensive care unit; SICU, surgical intensive care unit; CCU, cardiac intensive care unit; NA, not applicable.
https://doi.org/10.1371/journal.pone.0229416.t001
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genes. The ST that contained the most abundant AMR genes was ST208/ST1806. This ST pos-
sessed the class A extended-spectrum β-lactamase gene blaPER-1, which is a rare contributor of
antimicrobial resistance in A. baumannii, among others (Table 4).
The comparison of the total numbers of AMR genes based on the year of isolation showed
fluctuating results. The strains isolated in 2012 showed the most abundant AMR genes, while
those found in 2014 exhibited the least amount of these genes. In the latter part of the study
period, aac(3)-Ia, aac(6')-Ib, aac(6')-Ib3, aadA1, ant(3'')-Ia,blaTEM-1D, mph(E), sul1, and aac
(6')-Ib-cr were significantly decreased, while strA and tet(B) were increased. The change was
not significant upon separation and chronological comparison of only ST191 (Fig 3A and 3B).
Differences in virulence genes according to STs and year of isolation
From the literature survey, we compiled a list of 182 potential virulence genes [37]. Of all
genes identified, 107 genes were possessed by all of the isolated strains. The most differences
among STs were found in the ACICU_00075-ACICU_00087 (immune evasion), bap, csuA,
casuA/B, csuB, csuC, csuD, csuE, pgaD (biofilm formation), and vgrG1, vgrG2, and vgrG4 (Type
IV protein secretion system) genes (S6 Table). We separated ST191 and searched for epidemi-
ologic differences to find that only carO, related to porin, was more frequently detected in the
samples originating from the respiratory tract. No statistically significant chronological change
was observed (Table 5). The ST that possessed the most abundant virulence genes was ST208/
ST1809, which had more ACICU_00075-ACICU_00087, pgaD, blaPER-1, and hcp genes com-
pared to the others. The second most common type was ST451/ST1809, which possessed more
Fig 2. Core-gene based phylogenetic tree of 98 A. baumannii strains. Approximately maximum-likelihood tree was constructed from
2,520 core gene sequences (2,347,373 bp) using FastTree 2. Gray circles on branches represent local support values (0.9–1.0) based on
Shimodaira-Hasegawa test.
https://doi.org/10.1371/journal.pone.0229416.g002
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ACICU_00075-ACICU_00080, ACICU_00086, ACICU_00087, pgaD, pclC1, and hcp. ST552
had the fewest virulence genes and was devoid of blaOXA-24, ABUW_1966, ACICU_00074-A-
CICU_00087, fhaC, pgaD, blaPER-1, omp33-36, plcC1, and hcp. The ST that had the second few-
est virulence genes was ST447 (S6 Table).
The number of virulence genes was compared according to the year of isolation. The num-
ber increased as research period elapsed. The strains isolated in the year 2009 carried fewer
Table 2. Baseline characteristics of patients with carbapenem resistant A.baumannii bacteremia, grouped by sequence types.
Chracteristics Grouped by sequence type
ST191 ST447 Total
ST191(N = 59) Non ST191(N = 39) p-value ST447(n = 4) Non ST447(n = 94) p-value
Age, years 59.27±14.70 63.13±14.39 0.21 77.0±10.74 60.09±14.41 0.05 60.62±14.63
Gender, male 37(62.7) 32(84.2) 0.02 3(75.0) 66(71.0) 0.67 69(70.4)
Comorbidities
DM 43(72.9) 32(82.1) 0.23 2(50.0) 73(77.7) 0.24 75(67.5)
COPD 55(93.2) 37(94.9) 0.56 4(100.0) 88(93.6) 0.77 92(93.9)
CHF 49(83.1) 34(87.2) 0.42 4(100.0) 79(84.0) 0.51 83(84.7)
HTN 36(61.0) 26(66.7) 0.40 2(50.0) 60(63.8) 0.47 62(63.3)
CRF 42(71.2) 32(82.1) 0.18 3(75.0) 71(75.5) 0.69 74(75.5)
Chronic liver disease 52(88.1) 37(94.8) 0.24 4(100.0) 85(90.4) 0.60 89(90.8)
Malignancy 35(59.3) 22(56.4) 0.56 2(50.0) 55(58.5) 0.67 57(58.2)
Immunosuppressed status
Transplantation 7(11.9) 8(21/1) 0.18 0(0.0) 15(16.1) 0.50 15(15.3)
Steroid usea 20(33.9) 10(26.3) 0.29 0(0.0) 30(32.3) 0.22 30(30.6)
Chemotherapy 23(39.0) 16(42.1) 0.46 2(50.0) 37(39.8) 0.53 39(39.8)
APACHE II 21.32±8.16 21.26±7.18 0.97 23.25±3.50 21.22±7.881 0.35 21.17±7.81
Admission episode(� once) 42(71.19) 25(64.10) 0.27 3(75.0) 64(68.1) 0.62 67(68.4)
Source of infection
Respiratory tract 46(82.1) 32(88.9) 0.29 4(100.0) 74(78.7) 0.35 78(79.6)
Other 13(22.0) 7(17.9) 0(0.0) 20(21.3)
Time to bacteremia 21(12–41) 19(12–41) 0.38 12(8.2–37) 20.5(12–41) 0.21 20.5(12–41)
Invasive procedure
Ventilator 47(79.7) 33(86.8) 0.27 4(100.0) 76(81.7) 0.47 80(81.6)
CRRTx 18(30.5) 11(28.9) 0.53 2(50.0) 27(29.0) 0.35 29(29.6)
C-line insertion 52(88.1) 35(92.1) 0.40 4(100.0) 83(89.2) 0.64 87(88.8)
Operation 21(35.6) 8(21.1) 0.09 0(0.0) 29(31.2) 0.24 29(29.6)
Hospital stay (days) 32(20–57) 27(17–71) 0.77 17(17–41) 30(19–64.2) 0.04 30(19–64.2)
ICU stay (days) 22(11–38) 19(8–52) 0.34 17(15.5–33.5) 21(9.8–40.5) 0.34 21(9.8–40.5)
Duration of antibiotics 31(17–57) 25(16–69) 0.84 16.5(16–41) 30.5(16–59.3) 0.07 30.5(16–59.3)
Duration of susceptible antibiotics 0(0–9) 8(0–17) 0.36 4.5(0.3–10.8) 2(0–11.25) 0.76 2(0–11)
Susceptible antibiotics useb 4(6.8) 7(18.4) 0.08 1(25) 10(10.8) 0.39 11(11.2)
All cause 28 day mortality 52(88.1) 27(71.1) 0.16 4(100.0) 75(80.6) 0.81 79(80.6)
Data of sequence types only with statistical significance are shown. Data are expressed as the mean ± SD / median (Q1-Q3) or N (%). Abbreviation: DM, diabetes
mellitus; COPD, chronic obstructive pulmonary disease; CHF, congestive heart failure; HTN, hypertension; CRF, chronic renal failure; APACHE, acute physiology and
chronic health evaluation; CRRTx., continuous renal replacement therapy.
�signifies having statistical significance with p-value<0.05 when compared to groups of the rest.
a Steroid use defined by use of�20mg prednisolone for�2weeks.
b We consider antibiotics susceptible when phenotypically susceptible antibiotics were used for more than half of time after culture recovered.
https://doi.org/10.1371/journal.pone.0229416.t002
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virulence genes, while those isolated in 2015 exhibited more virulence genes compared to the
rest. We singled out ST191 and observed statistically insignificant results (Fig 4A and 4B).
Difference in ISAba1 and carbapenemase-encoding transposons on CRAB
ISAba1 belongs to the IS4 family and has been detected upstream of the ampC, blaOXA-23,
blaOXA-27, and sul2 antibiotic resistance genes in Acinetobacter species [34]. Insertion sites of
ISAba1 were different for each strain, and no common insertion sites were conserved
Table 3. Composition of antimicrobial resistant genes of all sequence types combined and sequence type 191 according to isolation date or source of bacteremia.
Genes ST191 All















aac(3)-Ia 29(63.0) 7(53.8) 0.39 34(91.9) 2(9.1) <0.01 38(70.4) 3(6.8) <0.01
aac(6')-Iaf 0(0.0) 0(0.0) 1.00 0(0.0) 0(0.0) 1.00 2(3.7) 0(0) 0.30
aac(6')-Ib 44(95.7) 13(100) 0.60 36(97.3) 21(95.5) 0.61 50(92.6) 29(65.9) <0.01
aac(6')-Ib3 44(95.7) 13(100) 0.60 37(100) 20(90.9) 0.14 51(94.4) 28(63.6) <0.01
aadA1 45(97.8) 13(100) 0.78 37(100) 21(95.5) 0.37 51(94.4) 29(65.9) <0.01
aadA1b 14(51.9) 0(0.0) <0.01 10(27.0) 4(18.1) 0.57 30(55.6) 17(68.6) 0.07
ant(3'')-Ia 44(95.7) 13(100) 0.60 37(100) 20(90.9) 0.14 51(94.4) 28(63.6) <0.01
aph(3')-Ia 0(0.0) 0(0.0) 1.00 0(0.0) 0(0.0) 1.00 6(11.1) 9(20.5) 0.16
aph(3'')-Ib 0(0.0) 0(0.0) 1.00 0(0.0) 0(0.0) 1.00 14(25.9) 15(34.1) 0.26
aph(6)-Id 0(0.0) 0(0.0) 1.00 0(0.0) 0(0.0) 1.00 14(25.9) 15(34.1) 0.26
aph(3')-VIb 0(0.0) 0(0.0) 1.00 0(0.0) 0(0.0) 1.00 3(5.6) 1(2.3) 0.39
aph(3')-Vij 1(2.2) 0(0.0) 0.78 1(2.7) 0(0.0) 0.63 4(7.4) 1(2.3) 0.25
armA 43(93.5) 13(100) 0.47 37(100) 19(86.4) 0.04 51(94.4) 37(84.1) 0.09
strA 4(8.7) 0(0.0) 0.36 0(0.0) 4(18.2) 0.02 14(25.9) 21(47.7) 0.02
b-lactam
blaADC-25 46(100) 13(100) 1.00 37(100) 22(100) 1.00 53(98.1) 40(90.9) 0.12
blaOXA-23 45(97.8) 13(100) 0.78 37(100) 21(95.5) 0.37 53(98.1) 43(97.7) 0.69
blaOXA-66 46(100) 13(100) 1.00 37(100) 22(100) 1.00 52(96.3) 39(90.7) 0.24
blaOXA-68 0(0.0) 0(0.0) 1.00 0(0.0) 0(0.0) 1.00 0(0) 3(6.8) 0.09
blaOXA-82 0(0.0) 0(0.0) 1.00 0(0.0) 0(0.0) 1.00 1(1.9) 2(4.5) 0.42
blaOXA-120 1(2.2) 0(0.0) 0.78 1(2.7) 0(0.0) 0.67 1(1.9) 0(0) 0.55
blaPER-1 0(0.0) 0(0.0) 1.00 0(0.0) 0(0.0) 1.00 3(5.6) 1(2.3) 0.39
blaTEM-1D 33(71.7) 7(53.8) 0.19 36(97.3) 4(18.2) <0.01 47(87.0) 12(27.3) <0.01
Microlide
mph(E) 37(80.4) 13(100) 0.08 35(94.6) 15(68.2) 0.01 49(90.7) 31(70.5) 0.01
msr(E) 41(89.1) 12(92.3) 0.60 34(91.9) 19(86.4) 0.40 48(88.9) 37(84.1) 0.34
Sulphonamide
sul1 45(97.8) 12(92.3) 0.40 37(100) 20(90.9) 0.14 51(94.4) 28(63.6) <0.01
sul2 0(0.0) 0(0.0) 1.00 0(0.0) 0(0.0) 1.00 12(22.2) 17(38.6) 0.06
Chloramphenicol
catB8 44(95.7) 12(92.3) 0.53 35(94.6) 21(95.5) 0.69 49(90.7) 29(65.9) <0.01
Quinolone
aac(6')-Ib-cr 40(86.9) 12(92.3) 0.35 45(97.8) 17(81.0) 0.12 50(92.6) 29(65.9) <0.01
Tetracycline
tet(B) 0(0.0) 0(0.0) 1.00 0(0.0) 0(0.0) 1.00 11(20.4) 18(40.9) 0.02
Data are expressed as N (%). Values with statistical significance (p-value<0.05) are expressed in boldface.
https://doi.org/10.1371/journal.pone.0229416.t003
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throughout all strains. Insertion sites of ISAba1 that were shared by more than 70% of strains
were designated as IS�1, IS�2, IS�3, IS�4, IS�5, IS�6, and IS�7. The compositions of IS�1
through IS�7 differed between STs (S7 Table). ST447 contained fewer insertion sequences
compared to the rest, while ST191 carried comparatively more insertion sequences; these inci-
dences remained constant throughout the study period for each insertion sequence (S1 Fig).






























aac(3)-Ia 36(61.0) 0(0) 3(100) 0(0.0) 0(0.0) 0(0.0) 1(33.3) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 2(100)
aac(6')-Iaf 0(0.0) 0(0) 2(66.7) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
aac(6')-Ib 57(96.6) 7(100) 1(33.3) 5(100) 0(0.0) 1(100) 3(100) 1(100) 1(100) 0(0.0) 1(25.0) 2(100)
aac(6')-Ib3 57(96.6) 7(100) 1(33.3) 5(100) 0(0.0) 1(100) 3(100) 1(100) 1(100) 0(0.0) 1(25.0) 2(100)
aadA1 58(98.3) 7(100) 1(33.3) 5(100) 0(0.0) 1(100) 3(100) 1(100) 1(100) 0(0.0) 1(25.0) 2(100)
aadA1b 29(50.0) 2(28.6) 3(100) 4(80.0) 0(0.0) 0(0.0) 1(33.3) 1(100) 1(100) 0(0.0) 1(25.0) 0(0.0)
ant(3'')-Ia 57(96.6) 7(100) 1(33.3) 5(100) 0(0.0) 1(100) 3(100) 1(100) 1(100) 0(0.0) 1(25.0) 2(100)
aph(3')-Ia 0(0.0) 3(42.9) 0(0.0) 4(80.0) 0(0.0) 1(100) 0(0.0) 0(0.0) 0(0.0) 7(63.6) 0(0.0) 0(0.0)
aph(3'')-Ib 0(0.0) 7(100) 2(66.7) 5(100) 0(0.0) 1(100) 3(100) 0(0.0) 0(0.0) 11(100) 0(0.0) 0(0.0)
aph(6)-Id 0(0.0) 7(100) 2(66.7) 5(100) 0(0.0) 1(100) 3(100) 0(0.0) 0(0.0) 11(100) 0(0.0) 0(0.0)
aph(3')-VIb 0(0.0) 0(0) 0(0.0) 4(80.0) 0(0.0) (0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
aph(3')-Vij 1(1.7) 0(0) 0(0.0) 4(80.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
armA 56(94.9) 7(100) 1(33.3) 5(100) 0(0.0) 1(100) 3(100) 1(100) 1(100) 10(90.9) 1(25.0) 2(100)
strA 4(6.8) 7(100) 2(66.7) 5(100) 0(0.0) 1(100) 2(66.7) 0(0.0) 0(0.0) 11(100) 1(25.0) 1(50.0)
b-lactam
blaADC-25 59(100) 7(100) 3(100) 5(100) 0(0.0) 1(100) 3(100) 1(100) 1(100) 11(100) 0(0.0) 2(100)
blaOXA-23 58(98.3) 7(100) 3(100) 5(100) 1(100) 1(100) 3(100) 1(100) 1(100) 11(100) 4(100) 2(100)
blaOXA-66 59(100) 7(100) 3(100) 5(100) 0(0.0) 1(100) 1(33.3) 1(100) 1(100) 11(100) 1(25.0) 2(100)
blaOXA-68 0(0.0) 0(0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 3(75.0) 0(0.0)
blaOXA-82 0(0.0) 0(0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 2(66.7) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
blaOXA-120 1(1.7) 0(0) 0(0.0) 0(0.0) 1(100) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
blaPER-1 0(0.0) 0(0) 0(0.0) 4(80.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
blaTEM-1D 40(67.8) 5(71.4) 3(100) 3(60) 0(0.0) 0(0.0) 1(33.3) 0(0.0) 0(0.0) 7(63.6) 0(0.0) 1(50.0)
Macrolide
mph(E) 50(84.7) 7(100) 1(33.3) 5(100) 0(0.0) 1(100) 3(100) 1(100) 1(100) 10(90.9) 0(0.0) 1(50.0)
msr(E) 53(89.8) 7(100) 1(33.3) 5(100) 0(0.0) 1(100) 3(100) 1(100) 1(100) 10(90.9) 1(25.0) 2(100)
Sulphonamide
sul1 57(96.6) 7(100) 1(33.3) 5(100) 0(0.0) 1(100) 3(100) 1(100) 1(100) 0(0.0) 1(25.0) 2(100)
sul2 0(0.0) 6(85.7) 2(66.7) 5(100) 0(0.0) 1(100) 0(0.0) 0(0.0) 0(0.0) 11(100) 4(100) 0(0.0)
Chloramphenicol
catB8 56(94.9) 7(100) 0(0.0) 5(100) 0(0.0) 1(100) 3(100) 1(100) 1(100) 0(0.0) 1(25.0) 2(100)
Quinolone
aac(6')-Ib-cr 52(88.1) 7(100) 1(33.3) 5(100) 0(0.0) 1(100) 3(100) 1(100) 1(100) 0(0.0) 1(25.0) 2(100)
Tetracycline
tet(B) 0(0.0) 7(100) 2(66.7) 1(20) 0(0.0) 1(100) 2(66.7) 0(0.0) 0(0.0) 11(100) 4(100) 0(0.0)
Data are expressed as N (%). Values with statistical significance (p-value<0.05) when compared to groups of the rest are expressed in boldface.
Abbreviation: ST, sequence type; NA, not applicable
https://doi.org/10.1371/journal.pone.0229416.t004
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We could detect common blaOXA-23-ΔATPase modules from all isolates with the exception of
ABAY11010 (ST369) and ABAY12016 (ST208/ST1806), which implied that Tn2006, Tn2008,
or Tn2009 was widespread among these strains. However, although antimicrobial resistance
(AMR) genes were predicted using three sets of contig sequences, which include assemblies
obtained by CLC Genomics Workbench (whole-genome assembly), by plasmid SPAdes, and
by plasmid profiler-based process, these cannot determine the exact location of AMR genes.
ABAY11010 and ABAY12016 originated in the respiratory tract, and had larger number of vir-
ulence and AMR genes than average (virulence genes, 160 and 161 copies each; AMR genes,
16 and 23 copies each). Both strains were isolated at different places (MICU D and MICU C
each) and times (2011 and 2012 each).
Resistance islands
AbaR1 is a commonly reported sequence from strains isolated in South Korea [38,39]. We
searched contig sequences using the 87.7-kb AbaR1 sequence from the strain AYE
(CU459141.1) [40] as a query, and found 70 strains to carry a very short AbaR-like sequence.
These were only 10,641 bp long after including the disrupted ATPase gene (comM’) at both
ends. AbaR-like islands were similar to the 14.5-kb long Tn6021 that is devoid of the multiple
antibiotic resistance region found in ATCC 17978 (GenBank CP00521.1). When read mapping
on the complete AbaR-like sequence extracted from ABAY09001 (GenBank
QHGS01000008.1; 56,153–66,793 bp) was applied, all strains except ABAY13016,
ABAY14002, ABAY14004, and ABAY14008 (all categorised as ST447) possessed AbaR-like
islands.
Also, 75 ABAY strains harbor class I integron carrying cat2, aadA1, sul1 and armA. It has
been reported that two consecutive copies of integrons are located within a putative resistance
island, but read mapping-based analysis (this study) could not reveal how integrons are situ-
ated in ABAY chromosomes. The gene organization is similar with class I integron identified
from NCGM 237 [41].
Fig 3. Changes in numbers of antimicrobial resistance genes according to year of isolation. Bar graph represents the medians,
percentiles (25th and 75th) and 95% confidence intervals: (A) when all sequence types were included and (B) when only sequence type
191 was included. Circle (�) and asterisk (�) symbols indicate extreme values. Pound (#) indicates a statistically significant result
(p<0.05) as compared to the rest of the year.
https://doi.org/10.1371/journal.pone.0229416.g003
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Table 5. Composition of virulence genes of all sequence types combined and sequence type 191 according to isolation date or source of bacteremia.
Genes ST191 ALL



















A1S_0009 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
A1S_0116 46(10) 13(100) 1 37(100) 22(100) 1 50(92.6) 39(88.6) 0.37
A1S_1180 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
A1S_1321 45(97.8) 13(100) 0.78 36(97.3) 22(100) 0.63 53(98.1) 44(100) 0.55
A1S_1386 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
A1S_1510 46(10) 13(100) 1 37(100) 22(100) 1 53(98.1) 44(100) 0.55
A1S_1921 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
A1S_2470 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
A1S_2525 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
A1S_3143 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
A1S_3175 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
A1S_3411 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ACV72173.1 43(93.5) 13(100) 0.47 34(91.9) 22(100) 0.24 46(85.2) 43(97.7) 0.03
ACV72174.1 43(93.5) 13(100) 0.47 34(91.9) 22(100) 0.24 47(87.0) 43(97.7) 0.06
ADB23465.1 43(93.5) 13(100) 0.47 34(91.9) 21(95.5) 0.52 47(87.0) 43(97.7) 0.06
ADB23466.1 39(84.8) 12(92.3) 0.43 31(83.8) 20(90.9) 0.36 40( 39(
ADB23467.1 43(93.5) 12(92.3) 0.64 34(91.9) 21(95.5) 0.52 47(87.0) 42(95.5) 0.14
ADB23468.1 43(93.5) 13(100) 0.47 34(91.9) 22(100) 0.24 47(87.0) 43(97.7) 0.06
ADB23470.1 43(93.5) 13(100) 0.47 34(91.9) 22(100) 0.24 47(87.0) 43(97.7) 0.06
ADB23471.1 40(87.0) 13(100) 0.21 33(89.2) 20(90.9) 0.60 45(83.3) 41(93.2) 0.126
ADB23472.1 37(80.4) 12(92.3) 0.29 28(75.7) 21(95.5) 0.07 41(75.9) 40(90.9) 0.04
ADB23473.1 42(91.3) 13(100) 0.36 33(89.2) 22(100) 0.15 46(85.2) 43(97.7) 0.03
GADB23474.1 43(93.5) 13(100) 0.47 34(91.9) 22(100) 0.24 46(85.2) 43(97.7) 0.03
GADB23475.1 43(93.5) 13(100) 0.47 34(91.9) 22(100) 0.24 47(87.0) 43(97.7) 0.06
blaOXA-24 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 0(0) 0(0) 1
Antibiotic resistance
ABUW_1156 46(10) 13(100) 1 37(100) 22(100) 1 53(98.1) 40(90.9) 0.12
ABUW_1499 43(93.5) 13(100) 0.47 36(97.3) 20(90.9) 0.31 45(83.3) 38(86.4) 0.45
ABUW_1520 41(89.2) 13(100) 0.27 35(94.6) 19(86.4) 0.26 45(83.3) 26(59.1) <0.01
ABUW_1645 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ABUW_1672 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ABUW_1673 46(10) 13(100) 1 37(100) 22(100) 1 53(98.1) 44(100) 0.55
ABUW_1692 45(97.8) 13(100) 0.78 36(97.3) 22(100) 0.63 53(98.1) 44(100) 0.55
ABUW_1755 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ABUW_1768 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ABUW_1849 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ABUW_1851 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ABUW_1966 46(10) 13(100) 1 37(100) 22(100) 1 0(0) 0(0) 1
ABUW_2074 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ABUW_2550 45(97.8) 13(100) 0.78 36(97.3) 22(100) 0.63 53(98.1) 44(100) 0.55
Aromatic hydrocarbon
metabolism
ABUW_2090 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ABUW_2123 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
(Continued)
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Table 5. (Continued)
Genes ST191 ALL


















ABUW_2236 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ABUW_2349 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ABUW_2370 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ABUW_2374 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
benP1 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
paaI1 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
paaY 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
pcaC 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
pcaD1 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
pcaU 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
Transcriptional regulation
ABUW_2520 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ABUW_2544 45(97.8) 13(100) 0.78 36(97.3) 22(100) 0.63 52(96.3) 44(100) 0.30
Immune evasion
ACICU_00074 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ACICU_00075 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 4(7.4) 12(27.3) <0.01
ACICU_00076 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 4(7.4) 12(27.3) <0.01
ACICU_00077 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 4(7.4) 12(27.3) <0.01
ACICU_00078 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 4(7.4) 12(27.3) <0.01
ACICU_00079 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 4(7.4) 12(27.3) <0.01
ACICU_00080 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 4(7.4) 12(27.3) <0.01
ACICU_00081 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 4(7.4) 1(2.3) 0.25
ACICU_00082 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 4(7.4) 1(2.3) 0.25
ACICU_00083 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 4(7.4) 1(2.3) 0.25
ACICU_00084 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 4(7.4) 1(2.3) 0.25
ACICU_00085 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 4(7.4) 1(2.3) 0.25
ACICU_00086 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 7(13.0) 15(34.1) 0.01
ACICU_00087 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 7(13.0) 15(34.1) 0.01
ACICU_00088 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ACICU_00089 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ACICU_00091 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ACICU_00092 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
lpsB 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
lptE 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
lpxA 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
lpxB 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
lpxC 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
lpxD 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
lpxL 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
lpxM 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
eps 46(10) 13(100) 1 37(100) 22(100) 1 43(79.6) 42(95.5) 0.02
pgi 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ptk 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ptp 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
(Continued)
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abaI 46(10) 13(100) 1 37(100) 22(100) 1 50(92.6) 39(88.6) 0.37
abaR 43(93.5) 11(84.6) 0.30 36(97.3) 18(81.8) 0.06 49(90.7) 35(79.5) 0.10
bfmR 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
bfmS 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
Killing of host cells
abeD 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
envZ 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
fhaB 45(97.8) 13(100) 0.78 36(97.3) 22(100) 0.63 52(96.3) 37(84.1) 0.04
fhaC 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 1(1.9) 0(0) 0.55
Biofilm formation
adeF 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
adeG 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
bap 46(10) 13(100) 1 37(100) 22(100) 1 53(98.1) 40(90.9) 0.12
csuA 44(95.7) 13(100) 0.61 37(100) 20(90.9) 0.14 47(87.0) 36(81.8) 0.33
csuA/B 44(95.7) 13(100) 0.61 37(100) 20(90.9) 0.14 47(87.0) 35(79.5) 0.23
csuB 44(95.7) 13(100) 0.61 37(100) 20(90.9) 0.14 47(87.0) 35(79.5) 0.23
csuC 44(95.7) 13(100) 0.61 37(100) 20(90.9) 0.14 47(87.0) 36(81.8) 0.33
csuD 44(95.7) 13(100) 0.61 37(100) 20(90.9) 0.14 47(87.0) 36(81.8) 0.33
csuE 44(95.7) 13(100) 0.61 36(97.3) 20(90.9) 0.31 46(85.2) 36(81.8) 0.43
pgaA 46(10) 13(100) 1 37(100) 22(100) 1 53(98.1) 44(100) 0.55
pgaB 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
pgaC 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 40(90.9) 0.04
pgaD 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 15(27.8) 19(43.2) 0.14
adeH 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
Antibiotic resisance
adeI 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
adeJ 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
adeK 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
blaPER-1 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 3(5.6) 1(2.3) 0.39
Transcriptional regulation
alkR 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
gigA 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
gigB 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
gigC 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
soxR 45(97.8) 13(100) 0.78 36(97.3) 22(100) 0.63 53(98.1) 44(100) 0.55
Iron uptake
barA 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
barB 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
basA 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
basB 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
basC 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
basD 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
basF 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
(Continued)
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basG 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
basH 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
basI 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
basJ 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
bauA 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 40(90.9) 0.04
bauB 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
bauC 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
bauD 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
bauE 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
bauF 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
nfuA 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
Porin
carO 46(100) 11(84.6) 0.046 37(100) 20(90.9) 0.14 54(100) 40(90.9) 0.04
omp22 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
omp33-36 0(0.0) 0(0.0) 1 37(100) 22(100) 1 0 0
ompR 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
orpD 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
Serun resistance, invasion
cipA 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
cobA 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
pbpG 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
surA1 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
tuf 46(10) 13(100) 1 36(97.3) 22(100) 0.63 53(98.1) 44(100) 0.55
typA 46(10) 13(100) 1 37(100) 22(100) 1
Enzyme
plcC1 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 8(14.8) 14(31.8) 0.05
plcC2 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
plcD 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
pldA 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
Cysteine metabolism
cysD 46(10) 13(100) 1 54(100) 44(100) 1
cysE 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
cysH 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
cysI 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
cysN 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
cysQ 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
sulP 46(10) 13(100) 1 37(100) 22(100) 1
Siderophore biosynthesis
entA 46(100) 13(100) 1 37(100) 22(100) 1 54(100) 42(95.5) 0.20
Neutrophil influx
gacS 46(10) 13(100) 1 54(100) 44(100) 1
paaA 45(97.8) 13(100) 0.78 36(97.3) 22(100) 0.63 53(98.1) 44(100) 0.55
Type II protein secretion
system
(Continued)
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Reconstruction of plasmid sequence
Assembly-based methods produced putative plasmidic contigs from all 98 isolates: average
total lengths of plasmidic contigs predicted by plasmiSPAdes and plasmid profiler-based uni-
cycler were 129,195.1 bp and 141,235 bp, respectively. Standard deviations of their total lengths
were 136,737.5 bp and 71,471.1 bp, respectively. The latter method, which relies on graph-
based assembly followed by circularization, identified 115 complete plasmid sequences along
with linear and complex type assemblies. We clustered plasmid sequences into groups based
on sequence similarity and length, which resulted in five groups ranging from 110,967 bp
Table 5. (Continued)
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gspD 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
Type VI protein secretion
system
vgrG1 46(10) 13(100) 1 37(100) 22(100) 1 39(72.2) 27(61.4) 0.29
vgrG2 46(10) 13(100) 1 37(100) 22(100) 1 52(96.3) 33(75.0) <0.01
vgrG3 46(10) 13(100) 1 37(100) 22(100) 1 53(98.1) 44(100) 0.55
vgrG4 46(10) 13(100) 1 37(100) 22(100) 1 40(74.1) 27(61.4) 0.20
hcp 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 12(22.2) 15(34.1) 0.14
Type V protein secretion
system
ata 41(89.1) 12(92.3) 0.60 31(83.8) 22(100) 0.08 42(77.8) 39(88.6) 0.13
Stress response genes
kef 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
kefF 45(97.8) 13(100) 0.78 36(97.3) 22(100) 0.63 54(100) 44(100) 1
mscS 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
ostB 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
recA 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
resP 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
trkH 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
upsA 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
uspA 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 0(0) 0(0) 1
uvrD 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 0(0) 0(0) 1
Manganese acquisition
system
mumC 45(97.8) 13(100) 0.78 36(97.3) 22(100) 0.63 52(96.3) 44(100) 0.30
mumT 45(97.8) 13(100) 0.78 36(97.3) 22(100) 0.63 52(96.3) 44(100) 0.30
Adherence
ompA 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
Micronutrient acquisition
znuA 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
znuB 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
znuC 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
zur 46(10) 13(100) 1 37(100) 22(100) 1 54(100) 44(100) 1
Data are expressed as N (%). Values with statistical significance (p-value<0.05) are expressed in boldface.
https://doi.org/10.1371/journal.pone.0229416.t005
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(group A) to 2,278 bp (group E) (S8 Table). To estimate the presence of all five groups of plas-
mids across strains, sequencing reads were re-mapped on the representative plasmid
sequences (S9 Table). Unexpectedly, we could not find any antimicrobial resistance genes
from the five representative plasmid sequences. However, unresolved plasmids in the plasmid
profiler-based unicycler assemblies might contain not-yet-identified ones that harbor multiple
AMR determinants.
We identified ISAba1, which is known to promote expression of downstream genes, from
four complete plasmids in group B. However, no blaOXA-23 was found in their vicinity or else-
where in the complete plasmid sequences.
Discussion
Since the 1970s, there has been a progressive increase in the antimicrobial resistance for the
majority of A. baumannii strains, which were otherwise sensitive to the commonly used antibi-
otics [42]. By 2007, up to 70% of isolates in certain settings had developed multidrug resistance
including resistance to carbapenems, which were once considered as the mainstay against mul-
tidrug-resistant A. baumannii infections [43]. In our study, ST191 was the dominant ST dur-
ing the 7 years of our study and showed stable genomic variations. However, when other STs
were combined, a tendency toward increasing virulence genes was observed without addi-
tional changes in antimicrobial resistance of CRAB in restricted hospital environments.
ST191 is a predominant strain isolated in South Korea [44] known for expressing blaOXA-
23, which is responsible for the high rate of carbapenem resistance. The trait that allows this
strain to emerge as a highly successful nosocomial pathogen through frequent modification of
genetic components was also manifested in our study. ST191 had higher insertion sequences
compared to the other types, indicating the frequent recombination and gene rearrangement
events. Also, only 60% of strains involved in our study had closed related strains identified in
previous studies. However, no cumulative change in AMR genes and virulence genes was
observed over time. The only gene that showed increased prevalence was strA. This gene is
related to aminoglycoside resistance and is frequently found in AbaR-like islands along with
Fig 4. Changes in numbers of virulence genes according to year of isolation. Bar graph represents medians, percentiles (25th and
75th), and 95% confidence intervals: (A) when all sequence types were included and (B) when only sequence type 191 was included.
Circle (�) and asterisk (�) symbols indicate extreme values. Pound (#) indicates a statistically significant result (p<0.05) as compared to
the rest of the year.
https://doi.org/10.1371/journal.pone.0229416.g004
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other genes such as tetA(B), tetR(B), CR2, strB, and orf4b [45]. We observed no simultaneous
increase in other AMR genes in this study.
It is worth noting that heterogenous groups of ST were isolated simultaneously. ST208/
ST1806 was the sequence type with the most abundant AMR genes; blaPER-1 was found only in
this sequence type. Although it is a relatively uncommon gene for A. baumannii, blaPER-1 is
frequently reported as being implicated in various virulence mechanisms [46,47]. In our study,
this strain was isolated mostly in 2012, and additional spread of this gene was not noted.
ST447, which was categorised into international clone 1 (IC I), was isolated in the latter part of
our study period. ST447 possessed fewer AMR genes. Since this strain was more frequently iso-
lated from patients with shorter hospital stays, it was introduced from the outside rather than
being an indigenous strain. This type was equipped with β-lactam resistance genes without
any other resistance genes. As with other strains, ST447 also had blaOXA-23-ΔATPase modules,
indicating that it carries Tn2006, Tn2008, or Tn2009. While Tn2006 was mostly transferred by
mobile elements, the spread of Tn2008 and Tn2009 was entirely dependent on the clonal dis-
semination of the bacterial host [44]. In light of ST447 containing all of these transposons, this
type might have been under selective antibiotic pressure for a long period of time. It is possible
that the previously susceptible strain may have gained genes only for carbapenem resistance
during the study period, but the widespread use of carbapenems may have contributed to the
emergence of this type. The density of virulence genes was still low, and this type of strain had
relatively lower insertion sequences, which are commonly found in other STs. This defies the
concern posed by a previous study in South Korea which reported the emergence of a new
strain that would provoke the dissemination of more antibacterial resistance [48].
Despite sporadic studies suggesting correlation between the number of virulence genes
with organisms’ phenotypic differences [16], the significance of number of virulence genes in
association with clinical outcomes and epidemiology has not been investigated. Therefore, the
increased number of virulence genes over time shown in our study demands immediate atten-
tion. Although previous studies suggested certain associations between antimicrobial resis-
tance and virulence [49], our study demonstrated that linear correlation between the two did
not exist. It is worth noting that more than half of the highly significant virulence genes were
possessed by all of these carbapenem-resistant strains. A slight increase in the number of viru-
lence genes was reported in 2015, probably due to the emergence of ST451/ST1809. ST451/
ST1809 possessed higher number of virulence genes than average (165 [159–166] vs. 158[138–
173], p<0.001). A gene specifically related to the functioning of porin (carO) [50] had
decreased, which may be attributed to enhanced antimicrobial resistance. However, genes that
were previously considered important in forming biofilms and iron utilization (bauA and
pgaC) [49,51] decreased in number. The increased genes were ACICU_00075-ACICU_00080,
ACICU_00086, and ACICU_00087, which are presumably associated with immune evasion
[52]. Although further evaluation is warranted regarding the authentic effects of these putative
virulence genes, the gradual accumulation of virulence genes that are transmitted by horizontal
transfer emphasises the need for more intensive infection control strategies to prevent re-
infections of CRAB.
We failed to observe any significant differences in patient outcomes according to STs. As
more than 80% of patients died within 28 days of the first isolation of the organism, it is possi-
ble that the patients were in serious condition and hence died before the analysis reached a
conclusive stage. However, previous studies also suggested that phenotypical characteristics
are not in accordance with genotypical results. It is possible that individual virulence factors
may not be important for A. baumannii virulence in human hosts [53], and the same virulence
factor may play different roles in different habitats [54]. The expression of virulence-associated
genes could be under different regulation in pathogenic and non-pathogenic species [55].
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We found no discrepancies between phenotypic and genotypic results in terms of carbape-
nem resistance. This observation confirmed the results of a previous study, in which WGS
accurately identified resistance to β-lactam antibiotics for gram-negative bacterial pathogens
[56]. Whether this observation holds true for other types of antimicrobial agents warrants fur-
ther studies.
The current study had a few limitations. First, only patients who were admitted to ICUs
were involved, limiting further epidemiological investigation. Second, the relationships
between strains, such as evolutionary linkages, were not determined. Third, detailed compara-
tive genomics to verify mechanisms of acquisition of virulence or AMR genes acquisition were
not analysed.
In conclusion, this study confirms the absence of accumulation of antimicrobial resistance
determinants while the number of virulence genes increases in CRAB. Genetic transfer
between subtypes cannot be ruled out; hence, it is important to be cautious about re-
infections.
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